Individual Differences in Response to Randomly Assigned Active Individualized Homeopathic and Placebo Treatment in Fibromyalgia: Implications of a Double-Blinded Optional Crossover Design

Journal of Alternative and Complementary Medicine

Volumn 10, Issue 2, 2004, Pages 269-283

  Bell, Iris R ^a,b,c,e   Lewis II, Daniel A ^b,d   Brooks, Audrey J ^b   Schwartz, Gary E ^a,b,c   Lewis, Sabrina E ^f   Caspi, Opher ^a,b   Cunningham, Victoria ^a,b   Baldwin, Carol M ^a,b,c,e  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b University of Arizona   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d SAYBROOK UNIVERSITY   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DECISION MAKING; DEPRESSION; DOUBLE BLIND PROCEDURE; EMOTIONAL DISORDER; FEMALE; FIBROMYALGIA; HEALTH STATUS; HOMEOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 1942510612     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/107555304323062266     Document Type: Article

References (77)

1. Aiken M. Participant-centered analysis in CAM comparative trials. J Altern Complement Med 2003;9:949-957.
2. Astin JA. Why patients use alternative medicine: Results of a national study. JAMA 1998;279:1548-1553.
3. Barsky AJ, Wyshak G, Klerman GL. The somatosensory amplification scale and its relationship to hypochondriasis. J Psychiatric Res 1990;24:323-334.
4. Bath PA. Self-rated health as a risk factor for prescribed drug use and future health and social service use in older people. J Gerontol Series A 1999;54:M565-M570.
5. Bell IR. Evidence-based homeopathy: Empirical questions and methodological considerations for homeopathic clinical research. Am J Homeopath Med 2003;96:17-31.
6. Bell IR, Baldwin CM, Schwartz GE. Translating a nonlinear systems theory model for homeopathy into empirical tests. Altern Ther Health Med 2002;8:58-66.
7. Bell IR, Koithan M, Baldwin CM, Gorman MM. Homeopathic practitioner views of changes in patients undergoing constitutional treatment for chronic disease. J Altern Complement Med 2003;9:39-50.
8. Bell IR, Lewis DA II, Brooks AJ, Schwartz GE, Lewis SE, Walsh BT, Baldwin CM. Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo. Rheumatology 2004a; in press.
9. Bell IR, Lewis DA II, Lewis SE, Schwartz GE, Scott A, Brooks AJ, Baldwin CM. Electroencephalographic alpha sensitization in individualized homeopathic treatment of fibromyalgia. Int J Neurosci 2004b; in press.
10. Bell IR, Warg-Damiani L, Baldwin CM, Walsh ME, Schwartz GE. Self-reported chemical sensitivity and wartime chemical exposures in Gulf War veterans with and without decreased global health ratings. Mil Med 1998;163:725-732.
11. Bernstein D, Fink L, Handelsman L. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry 1994;151:1132-1136.
12. Boscarino JA. Diseases among men 20 years after exposure to severe stress: Implications for clinical research and medical care. Psychosomat Med 1997;59:605-614.
13. Brown G, Nicassio P. Development of a questionnaire for the assessment of active and passive coping strategies in chronic pain patients. Pain 1987;31:53-64.
14. Caspi O, Bootzin RR. Evaluating how placebos produce change. Logical and causal traps and understanding cognitive explanatory mechanisms. Eval Health Prof 2002;25:436-464.
15. Challis GB, Stam HJ. A longitudinal study of the development of anticipatory nausea and vomiting in cancer chemotherapy patients: the role of absorption and autonomic perception. Health Psychol 1992;11:181-189.
16. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278-3285.
17. De Schepper L. LM potencies: One of the hidden treasures of the sixth edition of the Organon. Br Homoeopath J 1999;88:128-134.
18. DiMatteo MR, Hays R. The significance of patients' perceptions of physician conduct: A study of patient satisfaction in a family practice center. J Commun Health 1980;6:18-34.
19. Elia V, Niccoli M. Thermodynamics of extremely diluted aqueous solutions. Ann NY Acad Sci 1999;879:241-248.
20. Eltz MJ, Shirk SR, Sarlin N, Alliance formation and treatment outcome among maltreated adolescents. Child Abuse Neglect 1995;19:419-431.
21. Ernst E, Hahn EG, eds. Homeopathy. A Critical Appraisal. Oxford: Butterworth-Heinemann, 1998.
22. Ernst E, Resch KL. The 'optional cross-over design' for randomized controlled trials. Fundam Clin Pharmacol 1995;9:508-511.
23. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med 1998;14:245-258.
24. Fisher P, Greenwood A, Huskisson EC, Turner P, Belon P. Effect of homeopathic treatment on fibrositis (primary fibromyalgia). Br Med J 1989;299:365-366.
25. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-959.
26. Gliskey ML, Tataryn DJ, McConkey KM, Tobias BA, Kihlstrom JF. Absorption, openness to experience, and hypnotizability. J Person Soc Psychol 1991;60:263-272.
27. Golembiewski R, Billingsley K, Yeager S. Measuring change and persistence in human affairs: Types of change generated by OD designs. J Appl Behav Sci 1976;12:133-157.
28. Goodenow C, Reiseine S, Grady K. Quality of social support and associated social and psychological functioning in women with rheumatoid arthritis. Health Psychol 1990;9:266-284.
29. Gregerson MB, Roberts IM, Amiri MM. Absorption and imagery locate immune responses in the body. Biofeedback Self Regul 1996;21:149-165.
30. Hungelmann J, Kenkel-Rossi E, Klassen L, Stollenwerk R. Focus on spiritual well-being: Harmonious interconnectedness of mind-body-spirit-Use of the JAREL Spiritual Well-Being Scale. Geriatr Nurs 1996;17:262-266.
31. Hyland ME, Lewith GT. Oscillatory effects in a homeopathic clinical trial: An explanation using complexity theory, and implications for clinical practice. Homeopathy 2002;91:145-149.
32. Idler E, Benyamini Y. Self-rated health and mortality: A review of twenty-seven community studies. J Health Soc Behav 1997;38:21-36.
33. Jensen B, Wittrup IH, Rogind H, Danneskiold-Samsoe B, Bliddal H. Correlation between tender points and the Fibromyalgia Impact Questionnaire. J Musculoskeletal Pain 2000;8:19-29.
34. Jonas WB. The evidence house: How to build an inclusive base for complementary medicine. West J Med 2001;175:79-80.
35. Jonas W, Lin Y, Tortella F. Neuroprotection from glutamate toxicity with ultra-low dose glutamate. Neuroreport 2001;12:335-339.
36. Kane RL. Understanding Health Care Outcomes Research. Gaithersburg, MD: Aspen, 1997.
37. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:216-226.
38. Kennedy JE, Kanthamani H, Palmer J. Psychic and spiritual experiences, health, well-being, and meaning in life. J Parapsychol 1994;58:353-383.
39. Kirsch I, Moore TJ, Scoboria A, Nicholls SS. The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prevention & Treatment 2002; 5. Online document at: journals.apa.org/prevention/volume5/pre0050023a.html
40. Lasalvia A, Ruggeri M, Santolini N, Subjective quality of life: its relationship with clinician-rated and patient-rated psychopathology. The South-Verona Outcome Project 6. Psychother Psychosomat 2002;71:275-284.
41. Lau R, Ware J. Refinements in the measurement of health-specific locus of control beliefs. Med Care 1981;19:1147-1158.
42. Levin JS, Wickramasekera IE, Hirshberg C. Is religiousness a correlate of absorption? Implications for psychophysiology, coping, and morbidity. Altern Ther Health Med 1998;4:72-76.
43. Lorig KR, Stewart A, Ritter P, Gonzalez V, Laurent D, Lynch J. Outcome Measures for health Education and Other Health Care Interventions. Thousand Oaks, CA: Sage Publications, 1996.
44. Neff DF, Blanchard EB, Andrasik F. The relationship between capacity for absorption and chronic headache patients' response to relaxation and biofeedback treatment. Biofeedback Self Regul 1983;8:177-183.
45. Nelson PL. Personality attributes as discriminating factors in distinguishing religio-mystical from paranormal experients. Imagination Cogn Person 1992;11:389-406.
46. Nicassio PM, Schuman C, Kim J, Cordova A, Weisman MH. Psychosocial factors associated with complementary treatment use in fibromyalgia. J Rheumatol 1997;24:2008-2013.
47. Owens JE, Taylor AG, Degood D. Complementary and alternative medicine and psychologic factors: toward an individual differences model of complementary and alternative medicine use and outcomes. J Altern Complement Med 1999;5:529-541.
48. Peters D, ed. Understanding the Placebo Effect in Complementary Medicine. Theory, Practice, and Research. Edinburgh: Churchill-Livingstone, 2001.
49. Pioro-Boisset M, Esdaile JM, Fitzcharles MA. Alternative medicine use in fibromyalgia syndrome [comment]. Arthritis Care Res 1996;9:13-17.
50. Ratcliffe J, Van Haselen R, Buxton M, Hardy K, Colehan J, Partridge M. Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: A conjoint analysis study. Thorax 2002;57:503-508.
51. Rey L. Thermoluminescence of ultra-high dilutions of lithium chloride and sodium chloride. Physica A 2003;323:67-74.
52. Reynolds WM. Development of reliable and valid short forms of the Marlowe-Crowne Social Desirability Scale. J Clin Psychol 1982;38:119-125.
53. Rivers SM, Spanos NP. Personal variables predicting voluntary participation in and attrition from a meditation program. Psychol Rep 1981;49:795-801.
54. Rothman K. Fundamentals of epidemiologic data analysis. In: Modern Epidemiology. Boston: Brown, Little, and Co., 1986: 147-150.
55. Rowe T. Homeopathic Methodology. Repertory, Case Taking, and Case Analysis. Berkeley: North Atlantic Books, 1998.
56. Ruiz-Vega G, Perez-Ordaz L, Leon-Hueramo O, Cruz-Vazquez E, Sanchez-Diaz N. Comparative effect of Coffea cruda potencies on rats. Homeopathy. 2002;91:80-84.
57. Russek LG, Schwartz GE. Perceptions of parental caring predict health status in midlife: A 35-year follow-up of the Harvard Mastery of Stress Study. Psychosomat Med 1997;59:144-149.
58. Sirois FM, Gick ML. An investigation of the health beliefs and motivations of complementary medicine clients. Soc Sci Med 2002;55:1025-1037.
59. Slotkoff AT, Radulovic DA, Clauw DJ. The relationship between fibromyalgia and the multiple chemical sensitivity syndrome. Scand J Rheumatol 1997;26:364-367.
60. Smith B, Sechrest L. Treatment of Aptitude * Treatment interactions. J Consulting Clin Psychol 1991;59:233-244.
61. Sprangers MAG, van Dam, FSAM, Broerse J, Lodder L, Wever L, Visser RM, Oosterveld P, Smets E. Response shift and fatigue: The use of the thentest approach. Acta Oncol 1999;38:709-718.
62. Starace F, Ammassari A, Trotta MP, Murri R, De Longis P, Izzo C, Scalzini A, d'Arminio Monforte A, Wu AW, Antinori A. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquired Immune Defic Syndromes 2002;31:S136-S139.
63. Szarek MJ, Bell IR, Schwartz GE. Validation of a brief screening measure of environmental chemical sensitivity: The chemical odor intolerance index. J Environ Psychol 1997;17:345-351.
64. Tellegen A, Atkinson G. Openness to absorbing and self-altering experiences ("absorption"), a trait related to hypnotic susceptibility. J Abnorm Psychol 1974;83:268-277.
65. Tellegen A, Lykken DT, Bouchard TJ, Wilcox KJ, Segal NL, Rich S. Personality similarity in twins reared apart and together. J Pers Soc Psychol 1988;54:1031-1039.
66. Terborg JR, Maxwell SE, Howard GS. On the measurement and control of beta change: Problems with the Bedian, Armenakis, and Gibson technique. Acad Manage Rev 1982;7:292-295.
67. Unutzer J, Patrick DL, Marmon T, Simon GE, Katon WJ. Depressive symptoms and mortality in a prospective study of 2,558 older adults. Am J Geriatr Psychiatry 2002;10:521-530.
68. Vandenbroucke JP. Homeopathy trials: Going nowhere. Lancet 1997;350:824.
69. Vithoulkas G. The Science of Homeopathy. New York: Grove Weidenfeld, 1980.
70. Walach H. Magic of signs: A non-local interpretation of homeopathy. Br Homoeopath J 2000;89:127-140.
71. Walach H. The efficacy paradox in randomized controlled trials of CAM and elsewhere: Beware of the placebo trap. J Altern Complement Med 2001;7:213-218.
72. Walach H. Entanglement model of homeopathy as an example of generalised entanglement predicted by weak quantum theory. Forsch Komplementarmed Klass Naturheilkd 2003;10:192-200.
73. Walker EA, Keegan D, Gardner G, Sullivan M, Bernstein D, Katon WJ. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosomat Med 1997;59:572-577.
74. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002;17:504-511.
75. Wickramasekera I. Psychophysiological and clinical implications of the coincidence of high hypnotic ability and high neuroticism during threat perception in somatization disorders. Am J Clin Hypnosis 1994;37:22-33.
76. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-172.
77. Zachariae R, Jorgensen MM, Bjerring P, Svendsen G. Autonomic and psychological responses to an acute psychological stressor and relaxation: The influence of hypnotizability and absorption. Int J Clin Exp Hypnosis 2000;48:388-403.